Health
DLnano-vaccines may be a promising strategy for cancer immunotherapy – News-Medical.Net
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in the…
Reviewed by Emily Henderson, B.Sc.Sep 10 2020
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in therapeutic and prophylactic settings.
One of the advantages of synthetic DNA technologies over other methods is the versatility of the platforms. DLnano-vaccines may be designed for various cance…
-
Noosa News14 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
General17 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
General17 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General14 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa